Recently, a pharmaceutical company in Hunan province andNanjing Chemical Reagent Co., Ltd(referred to as "Nanjing Reagent")Reaching a deep cooperation, both parties will focus on the southern trial cardIsopropanol pharmaceutical excipientCollaborate closely to empower the high-quality development of the pharmaceutical industry with high-quality and compliant pharmaceutical excipients, providing a solid guarantee for drug production.

Nanjing reagent-Isopropanol pharmaceutical excipientThanks to its quality and strict compliance, it has successfully passed the National Center for Drug Evaluation(CDE) Publicity, CDE registration number: F20180000541（A）、F20190001878 、F20190000685（USP） 、F20200000172 （EP）、F20240000146（70% Isopropanol).Its appearance is a clear liquid with an odor similar to the mixture of ethanol and acetone. It has a slightly bitter taste, is flammable, and can be mixed with water and ethanol. It is insoluble in salt solutions. In terms of physical parameters, the melting point of this product is -88.5 ℃, the boiling point is 82.5 ℃, the density is about 0.785, and the refractive index is 1.4244. It needs to be sealed and stored to ensure stability. These characteristics make it widely applicable in the field of medicine, as a solvent for cordyceps, resins, nitrocellulose, etc. It can be used for esterification analysis and determination of plant oils, extraction of alkaloids, pesticide analysis, organic synthesis, and antifreeze combination. It also plays an important role in key links of biopharmaceuticals such as DNA precipitation.

This cooperation is not only a complementary advantage of both parties in the upstream and downstream of the pharmaceutical industry chain, but also a positive response to the development trend of "high quality and high compliance" of pharmaceutical excipients, jointly building a safe, efficient, and compliant pharmaceutical industry chain ecology.